从速释型半胱胺转换为缓释型半胱胺可能会降低疾病控制效果并增加额外的副作用。 - Suppr

Suppr

超能文献

Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effects.

作者信息

Bäumner Sören, Weber Lutz T

机构信息

Pediatric Nephrology, Children's and Adolescents' Hospital, University Hospital, Cologne, Germany.

出版信息

Pediatr Nephrol. 2017 Jul;32(7):1281-1282. doi: 10.1007/s00467-017-3618-3. Epub 2017 Mar 2.

DOI:10.1007/s00467-017-3618-3

PMID:28255804

Abstract

摘要

相似文献

Conversion from immediate- to extended-release cysteamine may decrease disease control and increase additional side effects.从速释型半胱胺转换为缓释型半胱胺可能会降低疾病控制效果并增加额外的副作用。

Pediatr Nephrol. 2017 Jul;32(7):1281-1282. doi: 10.1007/s00467-017-3618-3. Epub 2017 Mar 2.

Cystinosis: a new perspective.胱氨酸病：新视角

Acta Clin Belg. 2016 Jun;71(3):131-7. doi: 10.1179/2295333714Y.0000000113.

Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.半胱胺在肾移植中的应用：两例肾病性胱氨酸病患者的报告及移植后即刻成功重新开始半胱胺治疗

Pediatr Transplant. 2016 Feb;20(1):141-5. doi: 10.1111/petr.12617. Epub 2015 Oct 19.

Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.肾病性胱氨酸病患者从速释型半胱胺转换为缓释型半胱胺：一项回顾性真实单中心研究。

Pediatr Nephrol. 2017 Jan;32(1):91-97. doi: 10.1007/s00467-016-3438-x. Epub 2016 Jun 27.

A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis.关于酒石酸半胱胺治疗肾病性胱氨酸病的系统文献综述。

Curr Med Res Opin. 2017 Nov;33(11):2065-2076. doi: 10.1080/03007995.2017.1354288. Epub 2017 Aug 3.

Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.胱氨酸病：与胱氨酸消耗疗法依从性相关的肾小球和肾小管功能

Pediatr Nephrol. 2015 Jun;30(6):945-51. doi: 10.1007/s00467-014-3018-x. Epub 2014 Dec 20.

Suppository formulations as a potential treatment for nephropathic cystinosis.栓剂制剂作为治疗肾性胱氨酸病的一种潜在疗法。

J Pharm Sci. 2012 Oct;101(10):3729-38. doi: 10.1002/jps.23246. Epub 2012 Jul 6.

Nephropathic cystinosis in children: An overlooked disease.儿童肾性胱氨酸病：一种被忽视的疾病。

Saudi J Kidney Dis Transpl. 2009 May;20(3):436-42.

Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.半胱氨酸治疗可延缓晚期青少年和成年患者的囊纤维化肾病进展。

Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277. Epub 2011 Sep 7.

A deeper look into cysteamine absorption for the treatment of cystinosis.深入研究半胱胺吸收用于治疗胱氨酸病。

J Pediatr. 2006 Jun;148(6):718-9. doi: 10.1016/j.jpeds.2006.03.048.

引用本文的文献

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients.胱氨酸病患者使用的肠溶包衣酒石酸半胱胺

Pharmaceutics. 2023 Jun 29;15(7):1851. doi: 10.3390/pharmaceutics15071851.

The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study.挪威肾性胱氨酸病患者从速释型向缓释型半胱氨酸胺治疗转换的效果：一项回顾性研究。

Pediatr Nephrol. 2023 Nov;38(11):3671-3679. doi: 10.1007/s00467-023-06005-w. Epub 2023 May 23.

A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis.17 例肾性胱氨酸病患者中速释和迟释半胱氨酸的比较。

Orphanet J Rare Dis. 2021 Sep 14;16(1):387. doi: 10.1186/s13023-021-01991-2.

Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease.肾性胱氨酸病：一种全身性疾病的症状、治疗及展望

Front Pediatr. 2018 Mar 14;6:58. doi: 10.3389/fped.2018.00058. eCollection 2018.

本文引用的文献

Pediatr Nephrol. 2017 Jan;32(1):91-97. doi: 10.1007/s00467-016-3438-x. Epub 2016 Jun 27.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验